Ads
related to: best dividend drug stocks
Search results
Results from the WOW.Com Content Network
Shares of the stock are up by just 9.5% since the end of 2022 because of a huge patent cliff regarding its lead drug. Humira is an anti-inflammation injection that racked up $21.2 billion in sales ...
See the 10 stocks » *Stock Advisor returns as of December 16, 2024. Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie ...
AbbVie's 3.18% yield and 202% payout ratio reflect its post-Humira transition, with newer immunology drugs gaining traction to support its substantial dividend.
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...
An ideal stock for dividend and growth investors. David Jagielski (AbbVie): Drugmaker AbbVie is a solid all-around dividend stock, suitable for any type of investor. Its 3.2% dividend yield is ...
That makes AbbVie a top dividend stock. A high-yielding stock with a lot of upside. David Jagielski (Amgen): A solid dividend stock to buy this month is Amgen. The pharmaceutical company pays a ...
Ads
related to: best dividend drug stocks